The effect of vaccination to dendritic cell and immune cell interaction in HIV disease progression
From MaRDI portal
Publication:2788449
DOI10.1142/S1793524516500054zbMath1398.92151OpenAlexW2127591684MaRDI QIDQ2788449
Priti Kumar Roy, Amar Nath Chatterjee, Xue-Zhi Li
Publication date: 19 February 2016
Published in: International Journal of Biomathematics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1142/s1793524516500054
Related Items
A finite-difference discretization preserving the structure of solutions of a diffusive model of type-1 human immunodeficiency virus, Towards a new combination therapy with vectored immunoprophylaxis for HIV: modeling ``Shock and kill strategy, A statistical inference in an epidemic model with combinational drug treatment: HIV as a case study, How can HPV-induced cervical cancer be controlled by a combination of drug therapy? A mathematical study, MODELING MONOCYTE-DERIVED DENDRITIC CELLS AS A THERAPEUTIC VACCINE AGAINST HIV
Cites Work
- Distinct effects of protease and reverse transcriptase inhibition in an immunological model of HIV-1 infection with impulsive drug effects
- Drug resistance in an immunological model of HIV-1 infection with impulsive drug effects
- Modelling two different therapy strategies for drug T-20 on HIV-1 patients
- Can the viral reservoir of latently infected \(CD4^{+}\) T cells be eradicated with antiretroviral HIV drugs?
- Immunodominance analysis through interactions of CD8\(^+\) T cells and DCs in lymph nodes
- Explicitly accounting for antiretroviral drug uptake in theoretical HIV models predicts long-term failure of protease-only therapy
- Dynamics of HIV infection of CD4\(^ +\) T cells
- A model for treatment strategy in the chemotherapy of AIDS
- AN IMPULSIVE DIFFERENTIAL MODEL ON POST EXPOSURE PROPHYLAXIS TO HIV-1 EXPOSED INDIVIDUAL
- Anti-viral drug treatment along with immune activator IL-2: a control-based mathematical approach for HIV infection
